Genor Biopharma Holdings Limited (6998.HK)

HKD 1.66

(-5.68%)

Gross Profit Summary of Genor Biopharma Holdings Limited

  • Genor Biopharma Holdings Limited's latest annual gross profit in 2023 was - CNY , down -100.0% from previous year.
  • Genor Biopharma Holdings Limited's latest quarterly gross profit in 2024 Q2 was 7.06 Million CNY , down 0.0% from previous quarter.
  • Genor Biopharma Holdings Limited reported a annual gross profit of 14.94 Million CNY in annual gross profit 2022, down 0.0% from previous year.
  • Genor Biopharma Holdings Limited reported a annual gross profit of - CNY in annual gross profit 2021, down -100.0% from previous year.
  • Genor Biopharma Holdings Limited reported a quarterly gross profit of 7.06 Million CNY for 2024 Q1, down 0.0% from previous quarter.
  • Genor Biopharma Holdings Limited reported a quarterly gross profit of -31.37 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Gross Profit Chart of Genor Biopharma Holdings Limited (2023 - 2018)

Historical Annual Gross Profit of Genor Biopharma Holdings Limited (2023 - 2018)

Year Gross Profit Gross Profit Growth
2023 - CNY -100.0%
2022 14.94 Million CNY 0.0%
2021 - CNY -100.0%
2020 7.73 Million CNY 122.46%
2019 3.47 Million CNY 143.15%
2018 1.43 Million CNY 0.0%

Peer Gross Profit Comparison of Genor Biopharma Holdings Limited

Name Gross Profit Gross Profit Difference
Uni-Bio Science Group Limited 392.81 Million HKD 100.0%
CK Life Sciences Int'l., (Holdings) Inc. 947.7 Million HKD 100.0%